Oral Cannabidiol in the Treatment of Myofascial Pain Disorder of the Temporomandibular Region: A Placebo-Controlled Randomized Clinical Trial.
| Journal | Medical cannabis and cannabinoids |
| Study Type | Randomized Trial |
| Population | Human participants |
Temporomandibular disorders affect up to 12% of the population, often with limited effective treatment options. This represents the first randomized controlled trial specifically examining CBD for myofascial pain in the jaw region, addressing a significant clinical gap.
This double-blind, placebo-controlled RCT enrolled patients with temporomandibular myofascial pain disorder (baseline VAS ≥30) and randomized them to oral CBD versus placebo (hemp seed oil) for 3 months. The study measured pain reduction via visual analog scale and jaw function using the Jaw Functional Limitation Scale at 1, 2, and 3-month intervals. While the abstract is incomplete, this appears to be the first controlled trial targeting this specific pain condition with cannabinoids. The study design appropriately uses validated diagnostic criteria (DC/TMD) and established outcome measures.
“I’ve seen many patients with TMD who’ve tried CBD empirically with mixed results. Having controlled data specifically for this condition would be valuable, though I’d want to see the actual efficacy data, dosing protocols, and safety profile before changing my clinical approach.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Is CBD effective for treating temporomandibular joint (TMJ) pain?
This randomized controlled trial investigated oral CBD for myofascial pain disorder of the temporomandibular region, measuring pain relief at 1, 2, and 3 months using the Visual Analog Scale. While the study provides high-quality evidence due to its double-blind, placebo-controlled design, the specific results regarding CBD’s effectiveness are not detailed in the provided summary.
What dosage and form of CBD was used in this TMJ pain study?
The study used oral CBD compared to placebo (hemp seed oil) in patients with myofascial pain disorder. However, the specific dosage, frequency, and exact formulation of the oral CBD used in this clinical trial are not provided in the available study summary.
How long does it take for CBD to work for jaw pain?
This study measured outcomes at 1 month (primary endpoint), 2 months, and 3 months after treatment initiation. The research design suggests that meaningful pain relief, if present, would be evaluated at the 1-month mark, though earlier onset times were not specifically assessed in this trial.
Are there side effects of using CBD for TMJ disorders?
The study included adverse effects as an exploratory variable, indicating that safety was monitored throughout the trial. However, the specific adverse effects observed and their frequency compared to placebo are not detailed in the provided study summary.
Who is a good candidate for CBD treatment for jaw pain?
Study participants had significant pain (≥30 on Visual Analog Scale) and met the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for myofascial pain disorder. This suggests that CBD might be considered for patients with clinically diagnosed myofascial TMD and moderate to severe pain levels, though individual assessment by a healthcare provider is essential.
